Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Sell
31
XTNT Quote, Financials, Valuation and Earnings
Last price:
$0.61
Seasonality move
:
0%
Day range:
$0.63 - $0.67
52-week range:
$0.34 - $0.95
Dividend yield:
0%
P/E ratio:
62.25x
P/S ratio:
0.69x
P/B ratio:
1.76x
Volume:
232.4K
Avg. volume:
225.2K
1-year change:
9.31%
Market cap:
$88.9M
Revenue:
$117.3M
EPS (TTM):
$0.01
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
XTNT
Xtant Medical Holdings, Inc.
|
$30.8M | -- | -2.42% | -100% | $1.50 |
|
CATX
Perspective Therapeutics, Inc.
|
$231.1K | -$0.35 | -57.02% | -40.33% | $12.3077 |
|
INFU
InfuSystem Holdings, Inc.
|
$36.7M | $0.05 | 8.36% | 39.86% | $14.20 |
|
PMI
Picard Medical
|
-- | -- | -- | -- | -- |
|
VNRX
VolitionRX Ltd.
|
$714.1K | -$0.04 | 227.21% | -28.83% | $2.20 |
|
VTAK
Catheter Precision, Inc.
|
$310K | -$0.20 | 118.75% | -11.57% | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
XTNT
Xtant Medical Holdings, Inc.
|
$0.64 | $1.50 | $88.9M | 62.25x | $0.00 | 0% | 0.69x |
|
CATX
Perspective Therapeutics, Inc.
|
$2.5900 | $12.3077 | $192.5M | -- | $0.00 | 0% | 175.61x |
|
INFU
InfuSystem Holdings, Inc.
|
$8.65 | $14.20 | $175.9M | 33.08x | $0.00 | 0% | 1.30x |
|
PMI
Picard Medical
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
VNRX
VolitionRX Ltd.
|
$0.27 | $2.20 | $32.8M | -- | $0.00 | 0% | 18.30x |
|
VTAK
Catheter Precision, Inc.
|
$2.24 | -- | $2.8M | 0.40x | $0.00 | 0% | 10.53x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
XTNT
Xtant Medical Holdings, Inc.
|
39.2% | 3.120 | 35.76% | 1.08x |
|
CATX
Perspective Therapeutics, Inc.
|
1.35% | 3.042 | 1.3% | 8.47x |
|
INFU
InfuSystem Holdings, Inc.
|
30.8% | 4.042 | 11.73% | 1.35x |
|
PMI
Picard Medical
|
-- | 0.000 | -- | -- |
|
VNRX
VolitionRX Ltd.
|
-48.16% | 2.723 | 15.4% | 0.04x |
|
VTAK
Catheter Precision, Inc.
|
68.63% | 0.156 | 537.37% | 0.41x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
XTNT
Xtant Medical Holdings, Inc.
|
$22M | $2.5M | 2.15% | 3.78% | 7.64% | $4.2M |
|
CATX
Perspective Therapeutics, Inc.
|
-$566K | -$27.9M | -37.13% | -37.63% | -13330.62% | -$18.3M |
|
INFU
InfuSystem Holdings, Inc.
|
$20.3M | $3.8M | 6.43% | 9.93% | 10.45% | $8.4M |
|
PMI
Picard Medical
|
-- | -- | -- | -- | -- | -- |
|
VNRX
VolitionRX Ltd.
|
$318.2K | -$5.1M | -- | -- | -813.17% | -$3.5M |
|
VTAK
Catheter Precision, Inc.
|
-$320K | -$3M | -79.27% | -192.05% | -1336.73% | -$2.2M |
Xtant Medical Holdings, Inc. vs. Competitors
-
Which has Higher Returns XTNT or CATX?
Perspective Therapeutics, Inc. has a net margin of 3.93% compared to Xtant Medical Holdings, Inc.'s net margin of -12425.36%. Xtant Medical Holdings, Inc.'s return on equity of 3.78% beat Perspective Therapeutics, Inc.'s return on equity of -37.63%.
Company Gross Margin Earnings Per Share Invested Capital XTNTXtant Medical Holdings, Inc.66.13% $0.01 $82.9M CATXPerspective Therapeutics, Inc.-270.81% -$0.35 $245.5M -
What do Analysts Say About XTNT or CATX?
Xtant Medical Holdings, Inc. has a consensus price target of $1.50, signalling upside risk potential of 136.22%. On the other hand Perspective Therapeutics, Inc. has an analysts' consensus of $12.3077 which suggests that it could grow by 375.2%. Given that Perspective Therapeutics, Inc. has higher upside potential than Xtant Medical Holdings, Inc., analysts believe Perspective Therapeutics, Inc. is more attractive than Xtant Medical Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings XTNTXtant Medical Holdings, Inc.2 0 0 CATXPerspective Therapeutics, Inc.12 1 0 -
Is XTNT or CATX More Risky?
Xtant Medical Holdings, Inc. has a beta of -0.077, which suggesting that the stock is 107.701% less volatile than S&P 500. In comparison Perspective Therapeutics, Inc. has a beta of 1.182, suggesting its more volatile than the S&P 500 by 18.151%.
-
Which is a Better Dividend Stock XTNT or CATX?
Xtant Medical Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Xtant Medical Holdings, Inc. pays -- of its earnings as a dividend. Perspective Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XTNT or CATX?
Xtant Medical Holdings, Inc. quarterly revenues are $33.3M, which are larger than Perspective Therapeutics, Inc. quarterly revenues of $209K. Xtant Medical Holdings, Inc.'s net income of $1.3M is higher than Perspective Therapeutics, Inc.'s net income of -$26M. Notably, Xtant Medical Holdings, Inc.'s price-to-earnings ratio is 62.25x while Perspective Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xtant Medical Holdings, Inc. is 0.69x versus 175.61x for Perspective Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XTNTXtant Medical Holdings, Inc.0.69x 62.25x $33.3M $1.3M CATXPerspective Therapeutics, Inc.175.61x -- $209K -$26M
-
Which has Higher Returns XTNT or INFU?
InfuSystem Holdings, Inc. has a net margin of 3.93% compared to Xtant Medical Holdings, Inc.'s net margin of 6.19%. Xtant Medical Holdings, Inc.'s return on equity of 3.78% beat InfuSystem Holdings, Inc.'s return on equity of 9.93%.
Company Gross Margin Earnings Per Share Invested Capital XTNTXtant Medical Holdings, Inc.66.13% $0.01 $82.9M INFUInfuSystem Holdings, Inc.55.65% $0.11 $80.2M -
What do Analysts Say About XTNT or INFU?
Xtant Medical Holdings, Inc. has a consensus price target of $1.50, signalling upside risk potential of 136.22%. On the other hand InfuSystem Holdings, Inc. has an analysts' consensus of $14.20 which suggests that it could grow by 64.16%. Given that Xtant Medical Holdings, Inc. has higher upside potential than InfuSystem Holdings, Inc., analysts believe Xtant Medical Holdings, Inc. is more attractive than InfuSystem Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings XTNTXtant Medical Holdings, Inc.2 0 0 INFUInfuSystem Holdings, Inc.5 0 0 -
Is XTNT or INFU More Risky?
Xtant Medical Holdings, Inc. has a beta of -0.077, which suggesting that the stock is 107.701% less volatile than S&P 500. In comparison InfuSystem Holdings, Inc. has a beta of 1.680, suggesting its more volatile than the S&P 500 by 68.01%.
-
Which is a Better Dividend Stock XTNT or INFU?
Xtant Medical Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. InfuSystem Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Xtant Medical Holdings, Inc. pays -- of its earnings as a dividend. InfuSystem Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XTNT or INFU?
Xtant Medical Holdings, Inc. quarterly revenues are $33.3M, which are smaller than InfuSystem Holdings, Inc. quarterly revenues of $36.5M. Xtant Medical Holdings, Inc.'s net income of $1.3M is lower than InfuSystem Holdings, Inc.'s net income of $2.3M. Notably, Xtant Medical Holdings, Inc.'s price-to-earnings ratio is 62.25x while InfuSystem Holdings, Inc.'s PE ratio is 33.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xtant Medical Holdings, Inc. is 0.69x versus 1.30x for InfuSystem Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XTNTXtant Medical Holdings, Inc.0.69x 62.25x $33.3M $1.3M INFUInfuSystem Holdings, Inc.1.30x 33.08x $36.5M $2.3M
-
Which has Higher Returns XTNT or PMI?
Picard Medical has a net margin of 3.93% compared to Xtant Medical Holdings, Inc.'s net margin of --. Xtant Medical Holdings, Inc.'s return on equity of 3.78% beat Picard Medical's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XTNTXtant Medical Holdings, Inc.66.13% $0.01 $82.9M PMIPicard Medical-- -- -- -
What do Analysts Say About XTNT or PMI?
Xtant Medical Holdings, Inc. has a consensus price target of $1.50, signalling upside risk potential of 136.22%. On the other hand Picard Medical has an analysts' consensus of -- which suggests that it could fall by --. Given that Xtant Medical Holdings, Inc. has higher upside potential than Picard Medical, analysts believe Xtant Medical Holdings, Inc. is more attractive than Picard Medical.
Company Buy Ratings Hold Ratings Sell Ratings XTNTXtant Medical Holdings, Inc.2 0 0 PMIPicard Medical0 0 0 -
Is XTNT or PMI More Risky?
Xtant Medical Holdings, Inc. has a beta of -0.077, which suggesting that the stock is 107.701% less volatile than S&P 500. In comparison Picard Medical has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock XTNT or PMI?
Xtant Medical Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Picard Medical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Xtant Medical Holdings, Inc. pays -- of its earnings as a dividend. Picard Medical pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XTNT or PMI?
Xtant Medical Holdings, Inc. quarterly revenues are $33.3M, which are larger than Picard Medical quarterly revenues of --. Xtant Medical Holdings, Inc.'s net income of $1.3M is higher than Picard Medical's net income of --. Notably, Xtant Medical Holdings, Inc.'s price-to-earnings ratio is 62.25x while Picard Medical's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xtant Medical Holdings, Inc. is 0.69x versus -- for Picard Medical. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XTNTXtant Medical Holdings, Inc.0.69x 62.25x $33.3M $1.3M PMIPicard Medical-- -- -- --
-
Which has Higher Returns XTNT or VNRX?
VolitionRX Ltd. has a net margin of 3.93% compared to Xtant Medical Holdings, Inc.'s net margin of -862.39%. Xtant Medical Holdings, Inc.'s return on equity of 3.78% beat VolitionRX Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital XTNTXtant Medical Holdings, Inc.66.13% $0.01 $82.9M VNRXVolitionRX Ltd.50.73% -$0.05 -$24.7M -
What do Analysts Say About XTNT or VNRX?
Xtant Medical Holdings, Inc. has a consensus price target of $1.50, signalling upside risk potential of 136.22%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.20 which suggests that it could grow by 723.97%. Given that VolitionRX Ltd. has higher upside potential than Xtant Medical Holdings, Inc., analysts believe VolitionRX Ltd. is more attractive than Xtant Medical Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings XTNTXtant Medical Holdings, Inc.2 0 0 VNRXVolitionRX Ltd.4 2 0 -
Is XTNT or VNRX More Risky?
Xtant Medical Holdings, Inc. has a beta of -0.077, which suggesting that the stock is 107.701% less volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.234, suggesting its more volatile than the S&P 500 by 23.404%.
-
Which is a Better Dividend Stock XTNT or VNRX?
Xtant Medical Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Xtant Medical Holdings, Inc. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XTNT or VNRX?
Xtant Medical Holdings, Inc. quarterly revenues are $33.3M, which are larger than VolitionRX Ltd. quarterly revenues of $627.3K. Xtant Medical Holdings, Inc.'s net income of $1.3M is higher than VolitionRX Ltd.'s net income of -$5.4M. Notably, Xtant Medical Holdings, Inc.'s price-to-earnings ratio is 62.25x while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xtant Medical Holdings, Inc. is 0.69x versus 18.30x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XTNTXtant Medical Holdings, Inc.0.69x 62.25x $33.3M $1.3M VNRXVolitionRX Ltd.18.30x -- $627.3K -$5.4M
-
Which has Higher Returns XTNT or VTAK?
Catheter Precision, Inc. has a net margin of 3.93% compared to Xtant Medical Holdings, Inc.'s net margin of -1037.17%. Xtant Medical Holdings, Inc.'s return on equity of 3.78% beat Catheter Precision, Inc.'s return on equity of -192.05%.
Company Gross Margin Earnings Per Share Invested Capital XTNTXtant Medical Holdings, Inc.66.13% $0.01 $82.9M VTAKCatheter Precision, Inc.-141.59% -$1.70 $21.3M -
What do Analysts Say About XTNT or VTAK?
Xtant Medical Holdings, Inc. has a consensus price target of $1.50, signalling upside risk potential of 136.22%. On the other hand Catheter Precision, Inc. has an analysts' consensus of -- which suggests that it could grow by 1596.48%. Given that Catheter Precision, Inc. has higher upside potential than Xtant Medical Holdings, Inc., analysts believe Catheter Precision, Inc. is more attractive than Xtant Medical Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings XTNTXtant Medical Holdings, Inc.2 0 0 VTAKCatheter Precision, Inc.0 0 0 -
Is XTNT or VTAK More Risky?
Xtant Medical Holdings, Inc. has a beta of -0.077, which suggesting that the stock is 107.701% less volatile than S&P 500. In comparison Catheter Precision, Inc. has a beta of -1.392, suggesting its less volatile than the S&P 500 by 239.195%.
-
Which is a Better Dividend Stock XTNT or VTAK?
Xtant Medical Holdings, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Xtant Medical Holdings, Inc. pays -- of its earnings as a dividend. Catheter Precision, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XTNT or VTAK?
Xtant Medical Holdings, Inc. quarterly revenues are $33.3M, which are larger than Catheter Precision, Inc. quarterly revenues of $226K. Xtant Medical Holdings, Inc.'s net income of $1.3M is higher than Catheter Precision, Inc.'s net income of -$2.3M. Notably, Xtant Medical Holdings, Inc.'s price-to-earnings ratio is 62.25x while Catheter Precision, Inc.'s PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Xtant Medical Holdings, Inc. is 0.69x versus 10.53x for Catheter Precision, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XTNTXtant Medical Holdings, Inc.0.69x 62.25x $33.3M $1.3M VTAKCatheter Precision, Inc.10.53x 0.40x $226K -$2.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Is Palantir Stock Going to Crash?
AI and data analytics major Palantir (NASDAQ:PLTR) has become something…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
50
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
52
CVLT alert for Jan 27
Commvault Systems, Inc. [CVLT] is down 31.22% over the past day.
Buy
73
BNAI alert for Jan 27
Brand Engagement Network, Inc. [BNAI] is down 16.85% over the past day.
Buy
71
SANM alert for Jan 27
Sanmina Corp. [SANM] is down 21.58% over the past day.
